# Axsome Therapeutics, Inc. (AXSM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AXSM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 191.20M | $ -64.54M | $ -20.82M | $ 216.71M | $ 54.59M |
| 2025 | $ 653.76M | $ -187.55M | $ -96.13M | $ 241.30M | $ 88.30M |
| 2024 | $ 405.39M | $ -301.89M | $ -135.00M | $ 192.96M | $ 57.02M |
| 2023 | $ 292.59M | $ -258.68M | $ -157.50M | $ 186.37M | $ 190.98M |
| 2022 | $ 55.90M | $ -209.05M | $ -130.94M | $ 94.68M | $ 109.56M |
| 2021 | $ 0 | $ -155.00M | $ -128.64M | $ 49.71M | $ 15.63M |
| 2020 | $ 0 | $ -131.09M | $ -100.01M | $ 50.12M | $ 113.79M |
| 2019 | $ 0 | $ -88.22M | $ -59.88M | $ 19.93M | $ 178.72M |
| 2018 | $ 0 | $ -40.90M | $ -39.69M | $ 6.91M | $ 937.9K |
| 2017 | $ 0 | $ -38.99M | $ -35.67M | $ 9.93M | $ 16.72M |
| 2016 | $ 0 | $ -37.42M | $ -29.42M | $ 9.74M | $ 21.57M |
| 2015 | $ 0 | $ -14.83M | $ -10.47M | $ 0 | $ 46.44M |
| 2014 | $ 0 | $ -8.48M | $ -6.49M | $ 4.48M | $ -3.20M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 3.97 |
| Liabilities / Eq | 12.07 |
| Current Ratio | 1.39 |

## Other views

- [Metrics](https://sponda.capital/en/AXSM.md)
- [Charts](https://sponda.capital/en/AXSM/charts.md)
- [Compare](https://sponda.capital/en/AXSM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.